August 14, 2023

Picasso RSV vaccine Study: Evaluates the safety and immunogenicity of a single dose RSV vaccine in females or males, aged 2 years old to 17 years old who are at High Risk of RSV Disease.

The participant may be healthy or have a chronic condition that puts them at risk for severe disease. Blood samples will be required over the six month study period. Compensation for participation is available. To learn more, contact the UAB study team: 205-638-2629 or